“Novel compounds towards new treatment for cancer”

Professor Elias Arnér (Department of Medical Biochemistry and Biophysics) has identified novel compounds able to potently and specifically inhibit a target related to oxidative stress as a treatment of cancer. The technology has been licensed to a biotech company and is currently undergoing further development towards clinical testing. The commercial development was originally supported by Swedish Foundation for Strategic Research (SFF), Karolinska Institutet Innovations AB (KI Innovations) and Vinnova.